Industry Verticals »

All Categories

Insights »

About TMR »

Neurorehabilitation Devices Market

Neurorehabilitation Devices Market (Product: Neurorobotic Systems, Wearable Devices, Brain-computer Interface, and Brain Stimulators [Non-invasive Stimulators and Invasive Stimulators]; and Application: Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Brain & Spinal Cord Injury, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Gamification in Rehabilitation through VR Promises Early Treatment in Stroke Patients

With growing prominence of the startup culture, neuroscientists are exploring opportunities in virtual reality (VR) to speed up recovery in stroke patients. For instance, MindMaze - a startup neurotechnology company won several accolades for gamification in rehabilitation catering to stroke survivors with the help of VR and neuroscience. This is evident since stroke application segment accounted for 47% of the neurorehabilitation devices market in 2018. Thus, companies in the neurorehabilitation devices market should collaborate with neuroscientists to deliver inspiring results in stroke rehabilitation.

Healthcare companies are harnessing the advantages of VR, since there is only a short window when the brain can bounce back in early stages of treatment. Hence, VR and neuroscience have helped to maximize the potential for full recovery. Companies are increasing efforts to increase the availability of VR devices in hospitals.

neurorehabilitation devices market infographic

To know the scope of our report Get a Sample on Neurorehabilitation Devices Market?

New Multi-electrode Stimulation Proves Efficacious in Treatment of Spinal Cord Injuries

New technologies in electrostimulation are engulfing the neurorehabilitation devices market. Researchers are increasing R&D to develop a new multi-electrode to stimulate the spinal cord in different points to improve patient quality of life. For instance, the international team of Sissa (International School for Advanced Studies), Italy, collaborated with the researchers at the University of California, Los Angeles and the University of Leeds to develop a new multi-electrode for spinal cord stimulation. Thus, companies in the market for neurorehabilitation devices should collaborate with researchers to advance in spinal cord stimulation.

The new electrode is capable of deploying diversified electric message to different fibers of the cord in a targeted and independent manner. This innovation has aided in fast recovery of voluntary limb movements. Hence, companies in the neurorehabilitation devices market are increasing their research efforts in the field of electrical stimulation to enhance recovery of motor functions.

Get a glimpse of the in-depth analysis through our Report Brochure

The novel approach of electric stimulation of the spinal cord has been receiving attention in recent years. This is evident since the brain & spinal cord injury application segment is predicted for exponential growth in the market for neurorehabilitation devices. The global neurorehabilitation devices market is estimated to reach a revenue of US$ 3.2 Bn by the end of 2027.

Companies Combine Robotic Neurorehabilitation Devices with Non-invasive Brain Machine Interfaces

Robotic neurorehabilitation is acquiring prominence in the neurorehabilitation devices market. With the introduction of novel technologies, companies are able to enhance capabilities of robots to offer cost-effective solutions in clinical practice. However, lack of effective training modalities in these robotic devices poses as a restraint for healthcare companies in the neurorehabilitation devices market. Hence, companies are increasing their efficacy to design robotic devices with predefined training modalities depending on the appropriate control strategies.

Companies in the neurorehabilitation devices market are developing robots with passive and active training modalities where the robot is capable of imposing and modulating trajectories with respect to the patient’s intention to move. Companies in the neurorehabilitation devices market combining robot-aided neurorehabilitation with non-invasive brain machine interfaces. Robot-aided neurorehabilitation in combination with proper training regimen is also found to improve patient recovery. Companies are increasing the production of assistive controllers to aid movement in impaired limbs. Various strategies such as assist-as-needed are being widely employed to reduce patient reliance on robots to accomplish the rehabilitative task.

VR and FES Hold Promising Future in Wearable Devices

Since wearable technology is gaining prominence in every day-life applications, companies in the neurorehabilitation devices market are innovating in wristbands that have the potential to rehabilitate patients who have suffered from stroke. As such, wearable devices product segment of the neurorehabilitation devices market is projected for aggressive growth and the global neurorehabilitation devices market is projected to expand at a staggering CAGR of 12.5% during the forecast period.

Likewise, Facebook agreed to acquire brain-computing startup CTRL-labs that specializes in the neural interface technology and develops wristbands that delivers machine-interpretable commands. With the help of these novel wristbands, companies in the market for neurorehabilitation devices are tapping opportunities to improve recovery in patients suffering from multiple sclerosis, Parkinson’s disease, and other neurodegenerative diseases. Companies in the market for neurorehabilitation devices are also experimenting with VR systems and functional electrical stimulation (FES) to innovate in wearable technology.

neurorehabilitation devices market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Gamifying rehabilitation for stroke survivors with the help of VR has set the benchmark for innovation in the neurorehabilitation devices market. Neurorobotic systems and non-invasive brain stimulation have helped to enhance the quality and intensity of neurorehabilitation. Non-invasive brain stimulation is being combined with advanced technologies, such as functional MRI and near infrared spectroscopy, to treat neurological disorders.

Electric stimulation is acquiring popularity to restore lost functionality due to spinal cord injuries. However, physiological stimulus is lost after injury, which poses as a hurdle for healthcare companies. Hence, companies should innovate in the new multi-electrode stimulation technology to make the injured spinal cord more responsive to weak incoming messages coming from the brain.

Neurorehabilitation Devices Market: Overview

  • According to Transparency Market Research’s latest report on the neurorehabilitation devices market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of neurological disorders, aging population, technological advancements, entry of new players, and increase in access to healthcare are anticipated to drive the global neurorehabilitation devices market
  • According to the report, the global neurorehabilitation devices market was valued at US$ 1.12 Bn in 2018 and is projected to expand at a CAGR of 12.5% from 2019 to 2027

Rise in Prevalence of Neurological Disorders and Surge in Awareness about Usage and Benefits of Robotic Neurorehabilitation: A Key Driver

  • Rise in prevalence of neurological diseases has increased the patient pool undergoing interventional procedures followed by rehabilitation therapies globally, resulting in high demand for neurorehabilitation devices. Stroke is the leading cause of long-term disability in the U.S. Rise in prevalence of stroke across the world has increased the need of rehabilitation robotics technologies. According to the Internet Stroke Center, around 795,000 people suffer from stroke in the U.S. every year. Moreover, rise in prevalence of neuromotor disorders such as cerebral palsy, brain injury, and spinal cord injury globally drives demand for neurorobotic technologies, thereby fueling the growth of the neurorehabilitation devices market.
  • Manufacturers are making efforts to increase awareness among healthcare professionals and patients about the usage and benefits of neurorehabilitation robots. Neurorehabilitation robot manufacturers in developed countries such as the U.S. have begun to reach local communities by offering Continual Medical Education (CME) classes. This leads to increase in awareness among physicians and surgeons about the availability and usage of neurorehabilitation robots, thereby fueling the growth of the neurorehabilitation devices market.

Focus on Geographic Expansion

  • Companies in the global neurorehabilitation devices market are increasingly turning to in-licensing and collaboration agreements to launch new products in North America and Europe. Rise in demand for technology-driven solutions, economic growth, and increase in awareness about neurological disorders present significant opportunities for players operating in the global neurorehabilitation devices market.
  • According to industry experts, high cost of neurorehabilitation devices could hamper the market growth. This is particularly true for various underdeveloped and developing countries. Prevalence of neurological disorders is high in developing regions such as Asia, Africa, Latin America, and the Middle East. Hence, growth of neurorehabilitation devices is expected to be faster in these regions. However, high cost of neurorobotic systems and wearable devices would be a deterrent for exploiting the full potential of these regions.

Long Implantation Procedure, High Cost, and Lack of Skilled Professionals to Hamper Market

  • The global neurorehabilitation devices market is technology driven. Introduction of new technologies in the market increases the demand for these systems due to improved efficiency and outcomes. However, high cost of these new devices raises the affordability issue, which hampers the growth of the neurorehabilitation devices market, especially in the developing countries. Moreover, lack of reimbursement affects demand for neurorehabilitation devices.
  • Neurorehabilitation devices have been adopted by patients, therapists, and doctors in the last decade. However, standardization in training for product and accreditation guidelines to ensure physician competence and patience safety is still lacking. Hence, failure of neurorehabilitation devices has been observed during clinical practice, which results from product failure.

Neurorehabilitation Devices Market: Competition Landscape

  • This report profiles major players in the global neurorehabilitation devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The neurorehabilitation devices market is less fragmented with the presence of a few international as well as regional players
  • Leading players operating in the global neurorehabilitation devices market are
    • Bionik Laboratories Corp.
    • Ekso Bionics
    • ReWalk Robotics
    • Tyromotion GmbH
    • Boston Scientific Corporation
    • Medtronic plc
  • which account for more than 70% share of the market

Neurorehabilitation Devices Market: Key Developments

  • Key players in the global neurorehabilitation devices market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the neurorehabilitation devices market. A few expansion strategies adopted by players operating in the neurorehabilitation devices market are: 
  • In July 2019, Ekso Bionics expanded its medical exoskeleton portfolio by including an upper extremity rehabilitation device called EksoUE. In January 2019, Ekso Bionics entered into an agreement with Zhejiang Youchuang Venture Capital Investment Co., Ltd (ZYVC) to establish joint ventures for the development of a global exoskeleton manufacturing center and capture the potential exoskeleton market in China and other markets in Asia.
  • In December 2018, Bionik Laboratories Corp. entered into a multi-year agreement with Kindred Hospital Rehabilitation Services (‘Kindred’) for multiple units of the company's InMotion Arm robotic system
  • In June 2018, Bionik Laboratories Corp. entered into rental contract agreement with the Transitional Learning Center for InMotion Arm Robotic Systems. In May 2018, the company entered into rental agreement with Tallahassee Memorial HealthCare in Tallahassee, Florida, the U.S., for InMotion Arm robotic system.
  • The report on the neurorehabilitation devices market discussed individual strategies, followed by company profiles of manufacturers of neurorehabilitation devices. The ‘competition landscape’ section has been included in the neurorehabilitation devices market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global neurorehabilitation devices market.

Growing Prevalence of Neurological Disorders to Serve as a Vital Growth Booster for the Neurorehabilitation Devices Market

The incidence of neurological diseases is increasing at a rapid pace across the globe. The increase in neurological disorders such as Parkinson’s disease, stroke, and others will bring intensive growth opportunities for the neurorehabilitation devices market across the assessment period of 2019-2027.

  • According to the World Health Organization (WHO), the number of patients affected with neurological diseases will rise from 95 mn in 2015 to 103 mn in 2030. These alarming statistics point out the need for controlling the prevalence of these devices, eventually increasing the demand for neurorehabilitation devices.
  • The process of neurorehabilitation helps in reducing the disabilities and assists in improving the quality of life across patients. Neurorehabilitation devices assist in reducing the symptoms and improve the well-being of people having diseases such as trauma or disorder of the nervous system. The functionality attracts considerable opportunities for the neurorehabilitation devices market.
  • Technological advancements have brought great growth opportunities for the neurorehabilitation devices market. The focus of the players in the neurorehabilitation devices market on research and development activities is helping them to improve the products and provide more convenience to the end-users. These activities help in boosting the growth prospects across the neurorehabilitation devices market. Strategic collaborations are frequent. The frequent collaborations strengthen the foothold of the players, eventually leading to an increase in the growth rate.
  • The novel coronavirus pandemic has impacted the growth trajectory of various sectors and businesses. The neurorehabilitation devices market is no exception. The surging cases of COVID-19 around the world forced many countries to go into strict lockdowns. The lockdown measures resulted in the complete shutdown of various manufacturing units and production facilities.
  • Supply chain and logistics disruptions were also reported due to the border restrictions. All these aspects harmed the growth of the neurorehabilitation devices market. However, the relaxations in lockdown restrictions will help in diluting the negative effect.

Neurorehabilitation Devices Market – Segmentation

Product

Neurorobotic Systems

Wearable Devices

Brain-computer Interface

Brain Stimulators

  • Non-invasive Stimulators
  • Invasive Stimulators

Application

Stroke

Parkinson’s Disease

Multiple Sclerosis

Cerebral Palsy

Brain & Spinal Cord Injury

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of neurorehabilitation devices market?

Neurorehabilitation devices market is estimated to reach a revenue of US$ 3.2 Bn by the end of 2027

What is the anticipated CAGR of the neurorehabilitation devices market in the forecast period?

Neurorehabilitation devices market is projected to expand at a CAGR of 12.5% from 2019 to 2027

What are the key driving factors for the growth of the neurorehabilitation devices market?

Neurorehabilitation devices market is driven by rise in prevalence of neurological disorders, aging population and technological advancements

Who are the key players in the global neurorehabilitation devices market?

Key players in the global neurorehabilitation devices market include Bionik Laboratories Corp., Ekso Bionics, ReWalk Robotics, Tyromotion GmbH, Boston Scientific Corporation, Medtronic plc

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Neurorehabilitation Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Neurorehabilitation Devices Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Regulatory Scenario, by Region/Globally

        5.2. Funding

        5.3. Robotics Mergers & Acquisitions 

        5.4. Pricing Assessment

        5.5. Technological Advancements

        5.6. Recent Developments (Product approval, Installation, Launch, Partnership/Agreement)

    6. Global Neurorehabilitation Devices Market Analysis and Forecast, by Application

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Neurorehabilitation Devices Market Value Forecast, by Application, 2017–2027

            6.2.1. Stroke 

            6.2.2. Parkinson’s Disease

            6.2.3. Multiple Sclerosis 

            6.2.4. Cerebral Palsy

            6.2.5. Brain and Spinal Cord Injury

            6.2.6. Others

        6.3. Global Neurorehabilitation Devices Market Attractiveness, by Application

    7. Global Neurorehabilitation Devices Market Analysis and Forecast, by Product

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Neurorehabilitation Devices Market Value Forecast, by Product, 2017–2027

            7.2.1. Neurorobotic Systems 

            7.2.2. Wearable Devices 

            7.2.3. Brain-computer Interface

            7.2.4. Brain Stimulators

                7.2.4.1. Non-invasive Stimulators

                7.2.4.2. Invasive Stimulators

        7.3. Global Neurorehabilitation Devices Market Attractiveness, by Product 

    8. Global Neurorehabilitation Devices Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Neurorehabilitation Devices Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. North America Neurorehabilitation Devices Market Attractiveness, by Region

    9. North America Neurorehabilitation Devices Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            9.2.1. Stroke 

            9.2.2. Parkinson’s Disease

            9.2.3. Multiple Sclerosis 

            9.2.4. Cerebral Palsy

            9.2.5. Brain and Spinal Cord Injury

            9.2.6. Others

        9.3. North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

            9.3.1. Neurorobotic Systems 

            9.3.2. Wearable Devices 

            9.3.3. Brain-computer Interface

            9.3.4. Brain Stimulators

                9.3.4.1. Non-invasive Stimulators

                9.3.4.2. Invasive Stimulators

        9.4. North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Neurorehabilitation Devices Market Attractiveness Analysis 

            9.5.1. By Application

            9.5.2. By Product 

            9.5.3. By Country

    10. Europe Neurorehabilitation Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            10.2.1. Stroke 

            10.2.2. Parkinson’s Disease

            10.2.3. Multiple Sclerosis 

            10.2.4. Cerebral Palsy

            10.2.5. Brain and Spinal Cord Injury

            10.2.6. Others

        10.3. Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

            10.3.1. Neurorobotic Systems 

            10.3.2. Wearable Devices 

            10.3.3. Brain-computer Interface

            10.3.4. Brain Stimulators

                10.3.4.1. Non-invasive Stimulators

                10.3.4.2. Invasive Stimulators

        10.4. Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe 

        10.5. Europe Neurorehabilitation Devices Market Attractiveness Analysis 

            10.5.1. By Application

            10.5.2. By Product 

            10.5.3. By Country/Sub-region

    11. Asia Pacific Neurorehabilitation Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            11.2.1. Stroke 

            11.2.2. Parkinson’s Disease

            11.2.3. Multiple Sclerosis 

            11.2.4. Cerebral Palsy

            11.2.5. Brain and Spinal Cord Injury

            11.2.6. Others

        11.3. Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

            11.3.1. Neurorobotic Systems 

            11.3.2. Wearable Devices 

            11.3.3. Brain-computer Interface

            11.3.4. Brain Stimulators

                11.3.4.1. Non-invasive Stimulators

                11.3.4.2. Invasive Stimulators 

        11.4. Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific 

        11.5. Asia Pacific Neurorehabilitation Devices Market Attractiveness Analysis 

            11.5.1. By Application

            11.5.2. By Product 

            11.5.3. By Country/Sub-region

    12. Latin America Neurorehabilitation Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            12.2.1. Stroke 

            12.2.2. Parkinson’s Disease

            12.2.3. Multiple Sclerosis 

            12.2.4. Cerebral Palsy

            12.2.5. Brain and Spinal Cord Injury

            12.2.6. Others

        12.3. Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

            12.3.1. Neurorobotic Systems 

            12.3.2. Wearable Devices 

            12.3.3. Brain-computer Interface

            12.3.4. Brain Stimulators

                12.3.4.1. Non-invasive Stimulators

                12.3.4.2. Invasive Stimulators

        12.4. Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America Latin America 

        12.5. Latin America Neurorehabilitation Devices Market Attractiveness Analysis 

            12.5.1. By Application

            12.5.2. By Product 

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Neurorehabilitation Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            13.2.1. Stroke 

            13.2.2. Parkinson’s Disease

            13.2.3. Multiple Sclerosis 

            13.2.4. Cerebral Palsy

            13.2.5. Brain and Spinal Cord Injury

            13.2.6. Others

        13.3. Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

            13.3.1. Neurorobotic Systems

            13.3.2. Wearable Devices

            13.3.3. Brain-computer Interface

            13.3.4. Brain Stimulators

                13.3.4.1. Non-invasive Stimulators

                13.3.4.2. Invasive Stimulators

        13.4. Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa 

        13.5. Middle East & Africa Neurorehabilitation Devices Market Attractiveness Analysis 

            13.5.1. By Application

            13.5.2. By Product 

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by Tier and Size of companies)

        14.2. Market Share / Position Analysis by Company (2016)

        14.3. Competitive Business Strategies

        14.4. Company Profiles

            14.4.1. Bionik Laboratories Corp.

                14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.1.2. Growth Strategies

                14.4.1.3. SWOT Analysis

            14.4.2. Ekso Bionics

                14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.2.2. Growth Strategies

                14.4.2.3. SWOT Analysis

            14.4.3. Kinestica

                14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.3.2. Growth Strategies

                14.4.3.3. SWOT Analysis

            14.4.4. Neurostyle Pte Ltd

                14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.4.2. Growth Strategies

                14.4.4.3. SWOT Analysis

            14.4.5. Saebo, Inc.

                14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.5.2. Growth Strategies

                14.4.5.3. SWOT Analysis

            14.4.6. Reha Technology AG 

                14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.6.2. Growth Strategies

                14.4.6.3. SWOT Analysis 

            14.4.7. MindMaze Holding SA

                14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.7.2. Growth Strategies

                14.4.7.3. SWOT Analysis

            14.4.8. Neuro Device Group S.A.

                14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.8.2. Growth Strategies

                14.4.8.3. SWOT Analysis

            14.4.9. DIH Technologies Corporation (Hocoma)

                14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.9.2. Growth Strategies

                14.4.9.3. SWOT Analysis

            14.4.10. ReWalk Robotics

                14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.10.2. Growth Strategies

                14.4.10.3. SWOT Analysis

            14.4.11. Tyromotion GmbH

                14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.11.2. Growth Strategies

                14.4.11.3. SWOT Analysis

            14.4.12. Boston Scientific Corporation

                14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.12.2. Growth Strategies

                14.4.12.3. SWOT Analysis

            14.4.13. Medtronic plc

                14.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.13.2. Growth Strategies

                14.4.13.3. SWOT Analysis

    List of Tables

    Table 01: Number of DALYs for neurological disorders and as percentage of global DALYs projected for 2005, 2015, and 2030

    Table 02: Neurological disorders as percentage of total DALYs by WHO region, 2005 

    Table 03: Global Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 04: Global Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Brain Stimulators, 2017–2027

    Table 05: Global Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 06: Global Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 07: North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 08: North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 09: North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Brain Stimulators, 2017–2027

    Table 10: North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017?2027

    Table 11: Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 12: Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 13: Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Brain Stimulators, 2017–2027

    Table 14: Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017?2027

    Table 15: Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 16: Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 17: Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Brain Stimulators, 2017–2027

    Table 18: Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017?2027

    Table 19: Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 20: Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 21: Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Brain Stimulators, 2017–2027

    Table 22: Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017?2027

    Table 23: Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 24: Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 25: Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Brain Stimulators, 2017–2027

    Table 26: Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017?2027

    List of Figures

    Figure 01: Global Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017–2027

    Figure 02: Global Neurorehabilitation Devices Market Value Share (%), by Product, 2018

    Figure 03: Global Neurorehabilitation Devices Market Value Share (%), by Brain Stimulators, 2018

    Figure 04: Global Neurorehabilitation Devices Market Value Share (%), by Application, 2018

    Figure 05: Global Neurorehabilitation Devices Market Value Share (%), by Region, 2018

    Figure 6: Global Neurorehabilitation Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 7: Global Neurorehabilitation Devices Market Attractiveness, by Product, 2019–2027

    Figure 8: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Neurorobotic Systems, 2017–2027

    Figure 9: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wearable Devices, 2017–2027

    Figure 10: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Brain Stimulators, 2017–2027

    Figure 11: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Brain-computer Interface, 2017–2027

    Figure 12: Global Neurorehabilitation Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 13: Global Neurorehabilitation Devices Market Attractiveness, by Application, 2019–2027

    Figure 14: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stroke,

    Figure 15: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parkinson’s Disease, 2017–2027

    Figure 16: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Multiple Sclerosis, 2017–2027

    Figure 17: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cerebral Palsy, 2017–2027

    Figure 18: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Brain and Spinal Cord Injury, 2017–2027

    Figure 19: Global Neurorehabilitation Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others,

    Figure 20: Global Neurorehabilitation Devices Market Value Share Analysis, by Region, 2018 and 2027

    Figure 21: Global Neurorehabilitation Devices Market Attractiveness Analysis, by Region, 2019–2027

    Figure 22: North America Neurorehabilitation Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 23: North America Neurorehabilitation Devices Market Value Share Analysis, by Country, 2018 and 2027

    Figure 24: North America Neurorehabilitation Devices Market Attractiveness Analysis, by Country, 2019–2027

    Figure 25: North America Neurorehabilitation Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 26: North America Neurorehabilitation Devices Market Attractiveness, by Product, 2019–2027

    Figure 27: North America Neurorehabilitation Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 28: North America Neurorehabilitation Devices Market Attractiveness, by Application, 2019–2027

    Figure 29: Europe Neurorehabilitation Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 30: Europe Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 31: Europe Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 32: Europe Neurorehabilitation Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 33: Europe Neurorehabilitation Devices Market Attractiveness, by Product, 2019–2027

    Figure 34: Europe Neurorehabilitation Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 35: Europe Neurorehabilitation Devices Market Attractiveness, by Application, 2019–2027

    Figure 36: Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 37: Asia Pacific Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 38: Asia Pacific Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 39: Asia Pacific Neurorehabilitation Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 40: Asia Pacific Neurorehabilitation Devices Market Attractiveness, by Product, 2019–2027

    Figure 41: Asia Pacific Neurorehabilitation Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 42: Asia Pacific Neurorehabilitation Devices Market Attractiveness, by Application, 2019–2027

    Figure 43: Latin America Neurorehabilitation Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 44: Latin America Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 45: Latin America Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 46: Latin America Neurorehabilitation Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 47: Latin America Neurorehabilitation Devices Market Attractiveness, by Product, 2019–2027

    Figure 48: Latin America Neurorehabilitation Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 49: Latin America Neurorehabilitation Devices Market Attractiveness, by Application, 2019–2027

    Figure 50: Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 51: Middle East & Africa Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 52: Middle East & Africa Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 53: Middle East & Africa Neurorehabilitation Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 54: Middle East & Africa Neurorehabilitation Devices Market Attractiveness, by Product, 2019–2027

    Figure 55: Middle East & Africa Neurorehabilitation Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 56: Middle East & Africa Neurorehabilitation Devices Market Attractiveness, by Application, 2019–2027

    Figure 57: Bionik Laboratories Corp. R&D Expenses and General & Administrative Expenses (US$ Mn), 2018–2019

    Figure 58: Bionik Laboratories Corp. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

    Figure 59: Bionik Laboratories Corp. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018

    Figure 60: Bionik Laboratories Corp. R&D Expenses (US$ Mn), 2017 & 2018

    Figure 61: Bionik Laboratories Corp. Breakdown of Net Sales (%), by Region, 2018

    Figure 62: Bionik Laboratories Corp. Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 63: ReWalk Robotics Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

    Figure 64: ReWalk Robotics R&D Expenses (US$ Mn), 2016–2018

    Figure 65: ReWalk Robotics Gross Profit (US$ Mn), 2016–2018

    Figure 66: ReWalk Robotics Breakdown of Net Sales (%), by Region, 2018

    Figure 67: ReWalk Robotics Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 68 Boston Scientific Corporation Revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2018

    Figure 69: Boston Scientific Corporation Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 70: Boston Scientific Corporation R&D Intensity and Sales & Marketing Intensity – Company Level, (US$ Mn), 2017–2018

    Figure 71: Medtronic plc Revenue (US$ Bn) and Y-o-Y Growth (%),  2013–2018

    Figure 72: Medtronic plc R&D Intensity and Sales & Marketing Intensity – Company Level, 2017–2018

    Figure 73: Medtronic plc Breakdown of Net Sales, by Business Segment, 2018

    Figure 74: Medtronic plc Breakdown of Net Sales, by Region, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Neurorehabilitation Devices Market

Schedule a Call